Performance of risk prediction models for pancreatic cancer in patients with new-onset diabetes: a systematic review and meta-analysis
Existing PDAC risk prediction models for patients with NOD show moderate discrimination, however, substantial heterogeneity, limited independent external validation, incomplete calibration reporting, and inconsistent assessment of clinical utility constrain their immediate clinical translation.